Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Birgitte K Giersing"'
Autor:
Mark Jit, Rob Baltussen, Melanie Bertram, Praveen Thokala, Maarten Jansen, Dijana Spasenoska, Siobhan Botwright, Birgitte K Giersing, Martin I Meltzer, Anna-Lea Kahn, Nathalie El Omeiri, Joseph N-M Biey, Kelly L Moore, Jason M Mwenda, Raymond CW Hutubessy
Publikováno v:
BMJ Global Health, Vol 7, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/1f1b91541f21462cb568e9e374a8175a
Autor:
Mark S. Riddle, A. Louis Bourgeois, Allison Clifford, Suhi Jeon, Birgitte K. Giersing, Mark Jit, Marta Tufet Bayona, Jared Ovitt, William P. Hausdorff
Publikováno v:
Vaccine. 41:2634-2644
Autor:
Siobhan Botwright, Anna-Lea Kahn, Raymond Hutubessy, Patrick Lydon, Joseph Biey, Abdoul Karim Sidibe, Ibrahima Diarra, Mardiati Nadjib, Auliya A. Suwantika, Ery Setiawan, Rachel Archer, Debra Kristensen, Marion Menozzi-Arnaud, Ado Mpia Bwaka, Jason M. Mwenda, Birgitte K. Giersing
Publikováno v:
Vaccine: X, Vol 6, Iss , Pp 100078- (2020)
Innovations in vaccine product attributes could play an important role in addressing coverage and equity (C&E) gaps, but there is currently a poor understanding of the full system impact and trade-offs associated with investing in such technologies,
Externí odkaz:
https://doaj.org/article/395d6bfe81e44ef3878cfda5fe201d70
Autor:
Birgitte K. Giersing, Anna Janik Osborne, Anna-Lea Kahn, Jacqueline Anena, Joanie Robertson, Debra Kristensen, Tiziana Scarna, Mercy Mvundura, Collrane Frivold, Marion Menozzi-Arnaud, Sandeep Kumar, Abdoulaye Gueye, Priyanka Soni
Publikováno v:
Vaccine
As part of the Vaccine Innovation Prioritisation Strategy (VIPS), three immunization-stakeholder consultations were conducted between September 2018 and February 2020 to ensure that countries’ needs drove the prioritization of vaccine product innov
Autor:
Jean-Pierre Amorij, Anna-Lea Kahn, Darin Zehrung, Natasha Shah, Birgitte K. Giersing, Courtney Jarrahian, Marion Menozzi-Arnaud, Kristoffer Gandrup-Marino, Debra Kristensen
Publikováno v:
Vaccine
Highlights • A compelling public health need based on evidence is the foundation for product innovation. • Reaching the unreached with product innovations will require substantial investment. • Aligned partnership and sustained resources accele
Autor:
Maarten Jansen, Dijana Spasenoska, Siobhan Botwright, Birgitte K Giersing, Martin I Meltzer, Anna-Lea Kahn, Mark Jit, Rob Baltussen, Nathalie El Omeiri, Joseph N-M Biey, Kelly L Moore, Praveen Thokala, Jason M Mwenda, Melanie Bertram, Raymond CW Hutubessy
Publikováno v:
Abstracts.
Autor:
Patricia B. Pavlinac, Elizabeth T. Rogawski McQuade, James A. Platts-Mills, Karen L. Kotloff, Carolyn Deal, Birgitte K. Giersing, Richard A. Isbrucker, Gagandeep Kang, Lyou-Fu Ma, Calman A. MacLennan, Peter Patriarca, Duncan Steele, Kirsten S. Vannice
Publikováno v:
Vaccines; Volume 10; Issue 4; Pages: 489
Vaccine candidates for Shigella are approaching phase 3 clinical trials in the target population of young children living in low- and middle-income countries. Key study design decisions will need to be made to maximize the success of such trials and
Autor:
Christopher Troeger, Ben Lopman, Pete Smith, Holly J. Prudden, James A Platts-Mills, Mateusz Hasso-Agopsowicz, Claudio F. Lanata, Mark Jit, Robert E. Black, Laura M. Lamberti, Mark S Riddle, Raymond Hutubessy, Birgitte K. Giersing, Robert Reiner, Wilfred Ndifon, Virginia E. Pitzer, Gagandeep Kang, Robert F. Breiman
Publikováno v:
Vaccine
Investment in vaccine product development should be guided by up-to-date and transparent global burden of disease estimates, which are also fundamental to policy recommendation and vaccine introduction decisions. For low- and middle-income countries
Autor:
Ritika Kapoor, Yot Teerawattananon, Jos Luttjeboer, Waranya Rattanavipapong, Rachel A. Archer, Raymond Hutubessy, Siobhan Botwright, Birgitte K. Giersing
Publikováno v:
International Journal of Health Policy and Management
International Journal of Health Policy and Management, Vol 9, Iss 10, Pp 439-447 (2020)
International Journal of Health Policy and Management, Vol 9, Iss 10, Pp 439-447 (2020)
Background: The World Health Organization (WHO) has developed the Total System Effectiveness (TSE) framework to assist national policy-makers in prioritizing vaccines. The pilot was launched in Thailand to explore the potential use of TSE in a countr
Publikováno v:
Vaccines. 10(2)
The development and licensure of a safe and highly efficacious